Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06456073 · ClinicalTrials.gov registry record · Phase 1
E-CEL UVEC Treatment for Anal Fissures
A Phase 1 study of Chronic Anal Fissure, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT06456073 is a Phase 1 study of Chronic Anal Fissure that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 12 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06456073, a Phase 1 study of Chronic Anal Fissure, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial is being conducted by investigators who are colorectal surgeons. Eligible study participants will receive the experimental treatment E-CEL UVEC cells by direct injection into the anal fissure. The study is being conducted to determine if E-CEL UVEC cell injections will be safe and would have any effects on healing of the anal fissure.
Conditions Studied
Interventions
- BIOLOGICAL E-CEL UVEC cells (AB-207)
Study Locations (1)
New York
- Weill Cornell Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2024-09-12 |
| Est. Completion | 2026-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06456073
The ClinicalTrials.gov registry entry for NCT06456073 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Anal Fissure appearing as the primary indexed condition, and to 1 intervention - of which E-CEL UVEC cells (AB-207) is the first listed.
NCT06456073 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06456073 about?
NCT06456073 is a clinical study titled "E-CEL UVEC Treatment for Anal Fissures". This clinical trial is being conducted by investigators who are colorectal surgeons. Eligible study participants will receive the experimental treatment E-CEL UVEC cells by direct injection into the anal fissure. The study is being conducted to determine if E-CEL UVEC cell injections will be safe an...
What is the current status of trial NCT06456073?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2024-09-12. Estimated completion is 2026-12.
What conditions does trial NCT06456073 study?
This clinical trial studies the following conditions: Chronic Anal Fissure.
What interventions are being tested in trial NCT06456073?
The interventions under investigation include: E-CEL UVEC cells (AB-207) (BIOLOGICAL).
Who is sponsoring clinical trial NCT06456073?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06456073 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.